Vanda Pharma's Trade Secrets Suit Against FDA Moves Forward

By Dean Seal

A federal court has denied the government's bid to throw out a lawsuit from Vanda Pharmaceuticals accusing the Food and Drug Administration of handing trade secrets to generic drug makers.

Vanda said on Friday that the U.S. Court of Federal Claims permitted some of its claims against the government to proceed following oral arguments on a motion to dismiss last week.

The biopharmaceutical company said in its lawsuit filed in May that the FDA improperly provided confidential details about its sleep-wake disorder drug Hertlioz and its schizophrenia treatment Fanapt to generic drug manufacturers while it reviewed Vanda's new drug applications.

Vanda is seeking compensation and will now engage in discovery to support its claims, the company said Friday.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

January 19, 2024 16:42 ET (21:42 GMT)

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Mar 2024 to Apr 2024